Bharat Biotech reports positive data from Covid-19 booster dose trial
Antibody titers at day 28 following the booster vaccine were greater than those reported after the primary series.
India
Latest in
India
Bharat Biotech obtains approval to begin intranasal vaccine trials in India
The trials of the intranasal shot will enrol 5,000 healthy subjects who already received their primary vaccine regimen.
By
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
Akston doses first participants in Phase II Covid-19 vaccine trial in India
Results from the trial enrolling 100 healthy adult subjects are anticipated in January next year.
Inovio obtains approval for Phase III trial of Covid-19 vaccine in India
The trial will evaluate the efficacy of two doses of INO-4800 administered one month apart in adult subjects.
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end
The nasal spray is designed to offer hours of protection from a SARS-CoV-2 infection.
By
Indian pharma deals landscape shaped by Covid-19
The number of deals made in the Indian pharma market increased by 22% from 2019 to 2020, likely due to…
By
LTI and eClinicalHealth partner to decentralise clinical trials
As part of the partnership, LTI will help expedite the joint go-to-market pursuits and the deployment for Clinpal adopters.